Tyme Technologies, Inc . entered a new research collaboration with NYU Langone Health to advance the development of innovative treatments for patients with metastatic cancers, including pancreatic cancer. The broad collaboration will examine the effects of TYME’s cancer metabolism-based therapy, SM-88, and each of the components of MPS (methoxsalen, […]
TYME Technologies, NYU Langone to Advance Metastatic Cancer Treatment
